PAMP
ANIP icon

Polar Asset Management Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Polar Asset Management Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,000
Closed -$1.06M – 231
2015
Q1 		$1.06M Buy
+17,000
New +$1.03M 0.06% 168

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Polar Asset Management Partners's ANIP Position: Q2 2015 in Review

Polar Asset Management Partners sold out of ANI Pharmaceuticals (ANIP) in Q2 2015, closing a stake of 17,000 shares — an estimated $1.06M sold.

Polar Asset Management Partners first reported a position in ANIP in Q1 2015 and held it in 1 quarter. The position peaked at $1.06M in Q1 2015. 123 funds tracked by Wall St. Rank hold ANIP as of Q2 2015.

  • Polar Asset Management Partners reported no remaining ANI Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Polar Asset Management Partners sold 17,000 ANI Pharmaceuticals shares in Q2 2015, an estimated $1.06M.
  • Polar Asset Management Partners first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Polar Asset Management Partners's ANI Pharmaceuticals position peaked at $1.06M in Q1 2015.
  • 123 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2015.

Based on Polar Asset Management Partners's 13F filing for Q2 2015, filed 14 Aug 2015.